Exercise + GLP-1 Drug Combination: Does Physical Fitness Benefit Persist or Compete?
Exercise combined with GLP-1 RA treatment was evaluated for additive, synergistic, or competitive effects on physical fitness outcomes, providing evidence for optimal combination strategies.
Quick Facts
What This Study Found
Exercise + GLP-1 RA combination effects on physical fitness assessed, informing whether the interventions are additive, synergistic, or competitive for functional outcomes.
Key Numbers
How They Did This
Study evaluating physical fitness outcomes with exercise alone, GLP-1 RA alone, and combination treatment.
Why This Research Matters
Most GLP-1 drug users should exercise to preserve muscle, but how the two interventions interact for fitness is poorly understood.
The Bigger Picture
Optimizing the exercise-GLP-1 combination could maximize the benefit-to-risk ratio of obesity treatment.
What This Study Doesn't Tell Us
Specific outcome details in full paper.
Questions This Raises
- ?Does exercise fully compensate for GLP-1-induced lean mass loss?
- ?What exercise type (aerobic vs resistance) best complements GLP-1 therapy?
- ?Should exercise prescription change with GLP-1 dosing?
Trust & Context
- Key Stat:
- Exercise + GLP-1 Understanding how exercise and GLP-1 drugs interact for physical fitness is essential for optimizing millions of patients' treatment plans
- Evidence Grade:
- Controlled study with multiple intervention groups.
- Study Age:
- Published in 2025.
- Original Title:
- Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity.
- Published In:
- Sports medicine (Auckland, N.Z.) (2026)
- Authors:
- Jensen, Simon Birk Kjær(3), Fiorenza, Matteo, Juhl, Christian Rimer(2), Sandsdal, Rasmus Michael, Jensen, Emma, Seier, Søren Sonnenborg, Janus, Charlotte, Jørgensen, Julie Rehné, Blond, Martin Bæk, Holst, Jens Juul, Stallknecht, Bente Merete, Madsbad, Sten, Bandholm, Thomas, Torekov, Signe Sørensen
- Database ID:
- RPEP-15374
Evidence Hierarchy
Frequently Asked Questions
Should I exercise while on GLP-1 drugs?
Yes. This study examines how exercise and GLP-1 drugs interact for fitness. Exercise helps preserve muscle mass that GLP-1 drugs may reduce.
Does exercise make GLP-1 drugs work better?
They may be complementary — exercise preserves muscle while GLP-1 drugs reduce fat. The optimal combination strategy is what this study explores.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15374APA
Jensen, Simon Birk Kjær; Fiorenza, Matteo; Juhl, Christian Rimer; Sandsdal, Rasmus Michael; Jensen, Emma; Seier, Søren Sonnenborg; Janus, Charlotte; Jørgensen, Julie Rehné; Blond, Martin Bæk; Holst, Jens Juul; Stallknecht, Bente Merete; Madsbad, Sten; Bandholm, Thomas; Torekov, Signe Sørensen. (2026). Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity.. Sports medicine (Auckland, N.Z.). https://doi.org/10.1007/s40279-025-02386-0
MLA
Jensen, Simon Birk Kjær, et al. "Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity.." Sports medicine (Auckland, 2026. https://doi.org/10.1007/s40279-025-02386-0
RethinkPeptides
RethinkPeptides Research Database. "Physical Fitness with Exercise and GLP-1 Receptor Agonist Tr..." RPEP-15374. Retrieved from https://rethinkpeptides.com/research/jensen-2026-physical-fitness-with-exercise
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.